Measles: The Virus that Makes the Immune System Forget

Measles remains one of the most contagious viral infections affecting humans and continues to pose a substantial global health threat amid declining vaccination coverage. While its acute clinical manifestations such as fever, respiratory symptoms, conjunctivitis and a characteristic maculopapular rash are well recognized, accumulating evidence demonstrates that measles virus infection induces a profound and prolonged disruption of adaptive immunity termed immune amnesia. This phenomenon results from the viruses preferential infection and depletion of CD150 (a Signaling Lymphocytic Activation Molecule – SLAM family receptor) expressing memory B and T lymphocytes, leading to a measurable loss of previously acquired immune memory from past infections and vaccinations. Immune repertoire sequencing studies have shown that measles infection can eliminate 11%–73% of preexisting antibody diversity in affected children. Epidemiological data further indicate that measles outbreaks are followed by sustained increases in non-measles infectious disease morbidity and mortality for months or even years following recovery. These findings suggest that measles exerts broader immunological and population-level effects than previously appreciated. Vaccination remains the most effective intervention to prevent both acute disease and its long-term immunological sequelae. Strengthening global immunization programs and restoring public confidence in vaccines are therefore critical to mitigating extended public health consequences of measles-induced immune amnesia.